Skip to main content

Full text of "USPTO Patents Application 09993647"

See other formats


Clcl/ll Ullll# MUftl IU W Icily t;l 1 lt;l 1 1 ricocipi 


EFS ID: 


1768713 


Application Number: 


09993647 


International Application Number: 




Confirmation Number: 


1010 


Title of Invention: 


omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors 


First Named Inventor/Applicant Name: 


Bernd Riedl 


Customer Number: 


23599 


Filer: 


I. William Millen 


Filer Authorized By: 




Attorney Docket Number: 


BAYER 18A 


Receipt Date: 


11-MAY-2007 


Filing Date: 


27-NOV-2001 


Time Stamp: 


17:32:29 


Application Type: 


Utility 


Payment information: 


Submitted with Payment 


yes 


Payment was successfully received in RAM 


$180 


RAM confirmation Number 


905 


Deposit Account 




File Listing: 


Document Document Description File Name File Size(Bytes) D M . u ! fl . ,. Page ® 
Number K v 7 ' Part /.zip (ifappl.) 



1 


Information Disclosure Statement 


InformationDisclosureStatem 




no 




/|nc\ EilaH 


enio-i l -u/ .par 


32890 


4 


Warnings: 


Information: 


This is not an 


USPTO supplied IDS tillable form 












Information Disclosure Statement 




124006 






2 


(IDS) Filed 


IDS1449FORM-5-11-07.pdf 


no 


9 


Warnings: 


Information: 


This is not an 


USPTO supplied IDS tillable form 










3 


Foreign Reference 


EP0709225B1_TOT.pdf 


2373710 


no 


72 


Warnings: 


Information: 


4 


Foreign Reference 


WO0056331_TOT.pdf 


3383955 


no 


89 


Warnings: 


Information: 


5 


Foreign Reference 


WO02062763_TOT.pdf 


5240693 


no 


125 


Warnings: 


Information: 


6 


Foreign Reference 


WO02083628_TOT.pdf 


5812707 


no 


155 


Warnings: 


Information: 


7 


Foreign Reference 


WO02085857_TOT.pdf 


2905347 


no 


65 


Warnings: 


Information: 


8 


Foreign Reference 


WO02085859_TOT.pdf 


4380241 


no 


97 


Warnings: 


Information: 



9 


Foreign Reference 


WO03099771_TOT.pdf 


7914752 


no 


170 


Warnings: 


Information: 


10 


Foreign Reference 


WO9709973_TOT.pdf 


10826132 


no 


318 


Warnings: 


Information: 


11 


Foreign Reference 


W09932111-TOT.pdf 


5097241 


no 


126 


Warnings: 


Information: 


12 


NPL Documents 


AdjeietalAphaselstudy.pdf 


69532 


no 


1 


Warnings: 


Information: 


13 


NPL Documents 


AhmadetalKinaselnhibition.p 
df 


590309 


no 


5 


Warnings: 


Information: 


14 


NPL Documents 


AuclairetalBAY43-9006.pdf 


59931 


no 


1 


Warnings: 


Information: 


15 


NPL Documents 


Bankstonetal.pdf 


365909 


no 


5 


Warnings: 


Information: 


16 


NPL Documents 


Blancop38.pdf 


812373 


no 


9 


Warnings: 


Information: 


17 


NPL Documents 


Bollagetal.pdf 


525209 


no 


6 


Warnings: 


Information: 



18 


NPL Documents 


CampbelletallncreasingCom 
plexity.pdf 


2424350 


no 


19 


Warnings: 


Information: 


19 


NPL Documents 


ChangetalBay43-9006sorafe 
nib.pdf 


73262 


no 


1 


Warnings: 


Information: 


20 


NPL Documents 


CarterExperimentalMolecular 
TherapeuticsProceedingsoft 
heAmericanAssociationforCa 
ncerResearch.pdf 


1 73325 


no 


1 


Warnings: 


Information: 


21 


NPL Documents 


ClarketalSafetyandPharmac 
okinetics.pdf 


1034920 


no 


9 


Warnings: 


Information: 


22 


NPL Documents 


Cunninghametal.pdf 


529224 


no 


7 


Warnings: 


Information: 


23 


NPL Documents 


DansonetallmprovingOutcom 
es.pdf 


859338 


no 


11 


Warnings: 


Information: 


24 


NPL Documents 


DeGrendeleH.pdf 


222928 


no 


3 


Warnings: 


Information: 


25 


NPL Documents 


DumasDiscoverofanewclass 
p38.pdf 


269973 


no 


4 


Warnings: 


Information: 


26 


NPL Documents 


Dumasprotienkinaseinhibitor. 
pdf 


750454 


no 


10 


Warnings: 


Information: 



27 


NPL Documents 


DumasRecentdevelopments. 
par 


1279668 


no 


17 


Warnings: 


Information: 


28 


NPL Documents 


DumasSynthesisandparmac 
ological.pdf 


337191 


no 


4 


Warnings: 


Information: 


29 


NPL Documents 


EisenetalPhaseltrialofBAY.p 
df 


66103 


no 


1 


Warnings: 


Information: 


30 


NPL Documents 


Eisenhaueretallmpactofnewn 
on-cytotoxics.pdf 


512335 


no 


5 


Warnings: 


Information: 


31 


NPL Documents 


EscudieretalRandomizedPha 
selll.pdf 


71404 


no 


1 


Warnings: 


Information: 


32 


NPL Documents 


factsandcomparison.pdf 


662046 


no 


4 


Warnings: 


Information: 


33 


NPL Documents 


Garcia-LopezetalNewroutes. 
pdf 


42766 


no 


1 


Warnings: 


Information: 


34 


NPL Documents 


GeigeretalAntitumoractivity.p 
df 


545816 


no 


7 


Warnings: 


Information: 


35 


NPL Documents 


Hanson lnhibitorsofp38kinase 
.pdf 


49863 


no 


1 


Warnings: 


Information: 



36 


NPL Documents 


Hanson Pulmonary-Allergy. p 

UT 


291872 


no 


5 


Warnings: 


Information: 


37 


NPL Documents 


HeimetalAntitumoreffect.pdf 


157173 


no 


2 


Warnings: 


Information: 


38 


NPL Documents 


Hotteetal.pdf 


393065 


no 


5 


Warnings: 


Information: 


39 


NPL Documents 


HotteetalBAY43-9006.pdf 


393995 


no 


5 


Warnings: 


Information: 


40 


NPL Documents 


HubbardOncogenicMutations 
.pdf 


318340 


no 


3 


Warnings: 


Information: 


41 


NPL Documents 


IwadateetallntraarterialACN 
U.pdf 


96571 


no 


2 


Warnings: 


Information: 


42 


NPL Documents 


KempteretalSynthesepotenti 
eller.pdf 


1396625 


no 


20 


Warnings: 


Information: 


43 


NPL Documents 


Khireetal.pdf 


262018 


no 


4 


Warnings: 


Information: 


44 


NPL Documents 


Kuboetal.pdf 


1 73337 


no 


1 


Warnings: 


Information: 



45 


NPL Documents 


LeeandMcCubrey.pdf 


589793 


no 


7 


Warnings: 


Information: 


46 


NPL Documents 


LemoineReference.pdf 


936752 


no 


8 


Warnings: 


Information: 


47 


NPL Documents 


LowingerDesignandDiscover 
y.pdf 


627223 


no 


10 


Warnings: 


Information: 


48 


NPL Documents 


LowingerDiscoveryofanovel. 
pdf 


148604 


no 


1 


Warnings: 


Information: 


49 


NPL Documents 


LyonsetalDiscoveryofanovel. 
pdf 


816218 


no 


8 


Warnings: 


Information: 


50 


NPL Documents 


Madwedetal.pdf 


77971 


no 


1 


Warnings: 


Information: 


51 


NPL Documents 


MoellingetalSignalTransducti 
on. pdf 


845713 


no 


9 


Warnings: 


Information: 


52 


NPL Documents 


MooreetalPhaselstudytodete 
rmine.pdf 


576594 


no 


7 


Warnings: 


Information: 


53 


NPL Documents 


Mrossetal.pdf 


1 87834 


no 


2 


Warnings: 


Information: 



54 


NPL Documents 


MurphyetalBAY43-90006con 
trols.pdf 


71331 


no 


1 


Warnings: 


Information: 


55 


NPL Documents 


Reganetal.pdf 


1709151 


no 


15 


Warnings: 


Information: 


56 


NPL Documents 


MurtaetalFacileSynthesis.pdf 


1 68440 


no 


2 


Warnings: 


Information: 


57 


NPL Documents 


NickeletalCarboxylicacid.pdf 


415868 


no 


6 


Warnings: 


Information: 


58 


NPL Documents 


PankaetalBAY43-9006induc 
es.pdf 


43543 


no 


1 


Warnings: 


Information: 


59 


NPL Documents 


Redmanetal.pdf 


269247 


no 


4 


Warnings: 


Information: 


60 


NPL Documents 


RavietalActivatedRafl .pdf 


723840 


no 


7 


Warnings: 


Information: 


61 


Fee Worksheet (PTO-06) 


fee-info. pdf 


8194 


no 


2 


Warnings: 


Information: 


Total Files Size (in bytes) 


72119215 



This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents, 
characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt 
similar to a Post Card, as described in MPEP 503. 

New Applications Under 35 U.S.C. 111 

If a new application is being filed and the application includes the necessary components for a filing date (see 
37 CFR 1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date 
shown on this Acknowledgement Receipt will establish the filing date of the application. 

National Stage of an International Application under 35 U.S.C. 371 

If a timely submission to enter the national stage of an international application is compliant with the conditions 
of 35 U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the 
application as a national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, 
in due course. 

New International Application Filed with the USPTO as a Receiving Office 

If a new international application is being filed and the international application includes the necessary 
components for an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the 
International Application Number and of the International Filing Date (Form PCT/RO/105) will be issued in due 
course, subject to prescriptions concerning national security, and the date shown on this Acknowledgement 
Receipt will establish the international filing date of the application.